Featured Press Releases

LatigoBio_Logo

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

  • 24 Feb 2025

Vector Laboratories, a manufacturing partner of reagents and critical components for the...

IRBM Expands Functional Genomics Platform for Early Drug Discovery

IRBM Expands Functional Genomics Platform for Early Drug Discovery

Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop

Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop's NFC Anti-Counterfeit Tech

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

Exilby®, a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain, Receives Its First European Marketing Authorization from VERTANICAL; Pivotal U.S. Phase 3 Trial Underway

  • Vertanical
  • 09 Jun 2026
BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

BEACON Real-World Study Shows Positive Top-Line Results for ZUNVEYL® in Alzheimer’s Disease, Reports Alpha Cognition

  • Alpha Cognition Inc.
  • 09 Jun 2026
TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

TrueMed Selected by a Global Top-10 Pharmaceutical Company to Protect Three High-Volume Drug Brands Against Counterfeit Threats

  • TrueMed Ltd.
  • 08 Jun 2026
Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

Growing Demand for Digital Pharmacy Underscores TelyRx Surpassing 1 Million Prescriptions

  • TelyRx Holdings Inc.
  • 08 Jun 2026
Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

  • Beauty Crush Skincare
  • 04 Jun 2026
Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

  • Brain Navi Biotechnology
  • 04 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.